Health news

Actoverco Pharmaceutical Company

عناوین برگزیده

Selected titles

Actover Pharmaceutical Group Participates in the 10th IRAN PHARMA Exhibition

Actover Pharmaceutical Group, with active participation in the 10th edition of the Pharmaceutical and Related Industries Exhibition (IRAN PHARMA), hosted chief executives of several pharmaceutical

Actoverco Medical Director Stated: A Strong Commitment to the “Pharmacovigilance” System Ensures the Safety and Reliability of Actover Products

The first National Conference on “Health Product Vigilance” was held on the occasion of World Patient Safety Day by the Deputy for Food and Drug

Actover Group Unveils “Zeponim” for the Management of Multiple Sclerosis and Ulcerative Colitis

Here’s the English translation of that sentence: **The oral capsule *Zeponim* (Ozanimod), developed by specialists at Alborz Zagros Pharmaceutical Company — a subsidiary of Actover

Nexus CEO Calls for Equal Market Opportunities for Domestic Supplements at Iran Supplex 2025

Tehran, July 2025 – At the sidelines of the 13th Iran Supplex,Iran’s leading exhibition and congress for dietary, nutritional, and sports supplements.

Latest news

Introduction of Actoverco Cardiovascular Medications at the 8th International Heart Failure Congress

The 8th International Heart Failure Congress of Iran was held from December 7th to 9th, supported by the Actover pharmaceutical group, at the International Conference

The presence of Actover Pharmaceutical Group in the 2nd Pharmex Middle East Festival

Actover Group with more than 250 products and 2500 employees with 5 factories production lines in 15 therapeutic areas in various parts of production, marketing

Scientific Conference on the Effects of Hormone Replacement Therapy (HRT) in Menopause

The scientific seminar on the effects of hormone replacement therapy (HRT) during menopause, introducing Gynati and Prequin drugs by Ati Pharmed Pharmaceutical Company, was held.

Unveiling of 3 new drugs of Actoverco Company among the neurology group

On December 26, 2019, during a glorious ceremony attended by more than 180 psychiatrists and neurologists, three new drugs of Actoverco Company were officially unveiled.

Actoverco’s attendance at the 19th Iranian Congress of Gastroenterology and Hepatology

The 19th Iranian Congress of Gastroenterology and Hepatology was held from November 6 to 8 at the Razi International Conference Center.

Application of CPB technology in production of Actoverco’s Interferon beta 1-a

According to Actoverco’s Public Relations, we are currently producing the raw material of interferon beta-1a from the cell line in the Actover Group in the
The first specialized university - geriatric care Nahaleh Naraghi Dr. Alinasr naraghi

The first specialized university in the field of geriatric care was opened

The opening ceremony of the specialized scientific-applied university for the care of the elderly, with the efforts of the Zinda charity in memory of the

Inauguration of Actotech pharmaceutical and food accelerator with the presence of Dr. Sattari, Vice President for Science and Technology

According to the public relations of the Actover Group, Dr. Ali Naraghi at the opening of the pharmaceutical and food accelerator said: “This Corporation is

The effect of stress on digestive system

The gastrointestinal system and central nervous system are connected by different nerve fibers or neurons

Hygiene during wearing mask

Nowadays, one of the ways to reduce the spread of coronavirus and protection from it, is to use a mask

Thyroid hormone regulating drugs

The thyroid gland is responsible for secreting the thyroxine (T4) and triiodothyronine (T3) hormones.